Article Information
- Received October 24, 2011
- Revision received April 11, 2012
- Accepted April 23, 2012
- First published June 6, 2012.
- Version of record published June 6, 2012.
Author Information
Author contributions
Author contributions: C.M.W., M.L.A., R.C.R., C.J.S., M.W.A., M.P.F., and B.T.H. designed research; C.M.W., M.L.A., G.J.G., and D.K.R. performed research; C.M.W., M.L.A., G.J.G., and D.K.R. analyzed data; C.M.W., M.L.A., G.J.G., D.K.R., R.C.R., C.J.S., M.W.A., M.P.F., and B.T.H. wrote the paper.
Disclosures
- Received October 24, 2011.
- Revision received April 11, 2012.
- Accepted April 23, 2012.
This work was supported by NIH (Grants K08 NS069811 to C.M.W., R01 EY018742 to R.C.R., DP2 OD006662 to M.W.A.), by the Dr. and Mrs. E.P. Richardson Jr. Fund for Neuropathology (C.M.W.), by a fellowship from the Ludcke Foundation and Pierce Charitable Trust (M.L.A.), and by the Mathers Charitable Foundation (C.J.S.). We thank Anthony Moffa for assistance with data collection and Sergey Yurgenson and Aleksandr Vagodny for technical contributions. We thank members of the Shatz, Hyman, and Reid laboratories for advice and discussion.
- Correspondence should be addressed to Bradley T. Hyman, MassGeneral Institute for Neurodegenerative Disease, Neurology, Massachusetts General Hospital, 114 16th Street, Charlestown, MA 02129. bhyman{at}partners.org
